0090-9556/03/3109-1187-1197$20.00
DMD 31:1187-1197, 2003
CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
Jyrki Taskinen,
Brian T. Ethell,
Pia Pihlavisto1,
Alan M. Hood,
Brian Burchell, and
Michael W. H. Coughtrie
Department of Pharmacy, Viikki Drug Discovery Technology Center,
University of Helsinki, Helsinki, Finland (J.T., P.P.); and Department of
Molecular & Cellular Pathology, University of Dundee, Ninewells Hospital
& Medical School, Dundee, Scotland, United Kingdom (B.T.E., A.M.H., B.B.,
M.W.H.C.)
Conjugation of a structurally diverse set of 53 catechol compounds was
studied in vitro using six recombinant human sulfotransferases (SULTs), five
UDP-glucuronosyltransferases (UGT) and the soluble form of catechol
O-methyltransferase (S-COMT) as catalyst. The catechol set comprised
endogenous compounds, such as catecholamines and catecholestrogens, drugs,
natural plant constituents, and other catechols with diverse substituent
properties and substitution patterns. Most of the catechols studied were
substrates of S-COMT and four SULT isoforms (1A1, 1A2, 1A3, and 1B1), but the
rates of conjugation varied considerably, depending on the substrate structure
and the enzyme form. SULT1E1 sulfated fewer catechols. Only low activities
were observed for SULT1C2. UGT1A9 glucuronidated catechols representing
various structural classes, and almost half of the studied compounds were
glucuronidated at a high rate. The other UGT enzymes (1A1, 1A6, 2B7, and 2B15)
showed narrower substrate specificity for catechols, but each glucuronidated
some catechols at a high rate. Dependence of specificity and rate of
conjugation on the molecular structure of the substrate was characterized by
structure-activity relationship analysis and quantitative structure-activity
relationship modeling. Twelve structural descriptors were used to characterize
lipophilicity/polar interaction properties, steric properties, and electronic
effects of the substituents modifying the catechol structure. PLS models
explaining more than 80% and predicting more than 70% of the variance in
conjugation activity were derived for the representative enzyme forms SULT1A3,
UGT1A9, and S-COMT. Several structural factors governing the conjugation of
catechol hormones, metabolites, and drugs were identified. The results have
significant implications for predicting the metabolic fate of catechols.
Address correspondence to: Jyrki Taskinen, Department of Pharmacy,
Division of Pharmaceutical Chemistry, University of Helsinki, P.O. Box 56,
FIN-00014, Finland. E-mail:
jyrki.taskinen{at}helsinki.fi
This article has been cited by other articles:

|
 |

|
 |
 
K. Itaaho, M. H. Court, P. Uutela, R. Kostiainen, A. Radominska-Pandya, and M. Finel
Dopamine Is a Low-Affinity and High-Specificity Substrate for the Human UDP-Glucuronosyltransferase 1A10
Drug Metab. Dispos.,
April 1, 2009;
37(4):
768 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Loureiro, M. J. Bonifacio, C. Fernandes-Lopes, L. Almeida, L. C. Wright, and P. Soares-Da-Silva
Human Metabolism of Nebicapone (BIA 3-202), a Novel Catechol-O-Methyltransferase Inhibitor: Characterization of in Vitro Glucuronidation
Drug Metab. Dispos.,
November 1, 2006;
34(11):
1856 - 1862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Elovaara, J. Mikkola, L. Luukkanen, L. Antonio, S. Fournel-Gigleux, B. Burchell, J. Magdalou, and J. Taskinen
ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES
Drug Metab. Dispos.,
December 1, 2004;
32(12):
1426 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.